At a December press briefing, the Food and Drug Administration (FDA)
announced the seizure of 3000 bottles of EverCLR, a dietary supplement marketed
by Halo Supply Company of San Diego, Calif, in what the agency called an "example
of its commitment to strong enforcement . . . of unapproved drug claims."
The product was sold as a treatment for herpesvirus and protection from colds
The move comes shortly after the US Court of Appeals for the District
of Columbia Circuit restricted the FDA's authority to regulate dietary supplement
claims. Observers said the raid was an attempt to send a clear signal about
the types of claims that remain off-limits.
Vastag B. Supplement Enforcement Tightened. JAMA. 2003;289(3):290. doi:10.1001/jama.289.3.290-a